These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 28652557)

  • 21. Levalbuterol in the treatment of patients with asthma and chronic obstructive lung disease.
    Dalonzo GE
    J Am Osteopath Assoc; 2004 Jul; 104(7):288-93. PubMed ID: 15293593
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro dissolution and in vivo gamma scintigraphic evaluation of press-coated salbutamol sulfate tablets.
    Li W; Shi CH; Sheng YL; Cui P; Zhao YQ; Zhang XR
    Acta Pharm; 2013 Dec; 63(4):545-51. PubMed ID: 24451078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of exercise-induced bronchospasm in pediatric asthma patients: a comparison of salmeterol powder with albuterol.
    Blake K; Pearlman DS; Scott C; Wang Y; Stahl E; Arledge T
    Ann Allergy Asthma Immunol; 1999 Feb; 82(2):205-11. PubMed ID: 10071526
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulse nebulization in pneumatic devices.
    Gradoń L; Sosnowski TR; Podolec Z
    Int J Occup Saf Ergon; 1999; 5(1):31-42. PubMed ID: 10602637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (R)-salbutamol in the treatment of asthma and chronic obstructive airways disease.
    Patel M; Thomson NC
    Expert Opin Pharmacother; 2011 May; 12(7):1133-41. PubMed ID: 21453221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients.
    Lötvall J; Palmqvist M; Arvidsson P; Maloney A; Ventresca GP; Ward J
    J Allergy Clin Immunol; 2001 Nov; 108(5):726-31. PubMed ID: 11692096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous versus intermittent nebulization of salbutamol in acute severe asthma: a randomized, controlled trial.
    Besbes-Ouanes L; Nouira S; Elatrous S; Knani J; Boussarsar M; Abroug F
    Ann Emerg Med; 2000 Sep; 36(3):198-203. PubMed ID: 10969220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions.
    Akapo S; Gupta J; Martinez E; McCrea C; Ye L; Roach M
    Ann Pharmacother; 2008 Oct; 42(10):1416-24. PubMed ID: 18780805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enantioselective resolution of Rac-terbutaline and evaluation of optically pure R-terbutaline hydrochloride as an efficient anti-asthmatic drug.
    Beng H; Zhang H; Jayachandra R; Li J; Wu J; Tan W
    Chirality; 2018 Jun; 30(6):759-768. PubMed ID: 29569746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative studies on pirbuterol, salbutamol and a placebo administered as an aerosol in asthmatic patients].
    Verstraeten JM
    Rev Inst Hyg Mines (Hasselt); 1978; 33(4):200-3. PubMed ID: 552144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative therapeutic effect of bronchodilator aerosols and salbutamol cyclocaps].
    Ninković M; Bjelajac D; Ranković B; Dangubić V; Plavec G
    Vojnosanit Pregl; 1993; 50(6):589-92. PubMed ID: 8197732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A new aerosol adrenergic bronchodilator, procaterol. Comparative study of salbutamol and procaterol].
    Morin D; Milot J; Turcotte H; Boulet LP
    Union Med Can; 1987 Apr; 116(4):215-8. PubMed ID: 2885957
    [No Abstract]   [Full Text] [Related]  

  • 33. Determination of nebulizer droplet size distribution: a method based on impactor refrigeration.
    Berg E; Svensson JO; Asking L
    J Aerosol Med; 2007; 20(2):97-104. PubMed ID: 17536948
    [TBL] [Abstract][Full Text] [Related]  

  • 34. (R,S)-salbutamol plasma concentrations in severe asthma.
    Jacobson GA; Chong FV; Wood-Baker R
    J Clin Pharm Ther; 2003 Jun; 28(3):235-8. PubMed ID: 12795782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pirbuterol and salbutamol aerosol for exercise-induced bronchoconstriction].
    Aebischer JC; Benoit RC; Scherrer M
    Schweiz Med Wochenschr; 1984 Nov; 114(46):1660-4. PubMed ID: 6515368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of the effects of the R- and S-enantiomers of salbutamol on equine isolated bronchi.
    Matera MG; Calzetta L; Rogliani P; Bardaro F; Page CP; Cazzola M
    Pulm Pharmacol Ther; 2011 Apr; 24(2):221-6. PubMed ID: 21195788
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of force control agents in high-dose dry powder inhaler formulations.
    Begat P; Morton DA; Shur J; Kippax P; Staniforth JN; Price R
    J Pharm Sci; 2009 Aug; 98(8):2770-83. PubMed ID: 19067395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy of pulmicort suspension plus salbutamol and ipratropium bromide for management of acute asthma exacerbation in children: a comparative study].
    Chen ZG; Li M; Chen H; Chen YF; Chen FH; Ji JZ
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):470-2. PubMed ID: 18359717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation of in vitro/in vivo correlations for salbutamol nebulized by eight systems.
    Silkstone VL; Dennis JH; Pieron CA; Chrystyn H
    J Aerosol Med; 2002; 15(3):251-9. PubMed ID: 12396413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term comparison of salbutamol powder with salbutamol aerosol in asthmatic out-patients.
    Hartley JP; Nogrady SG; Seaton A
    Br J Dis Chest; 1979 Jul; 73(3):271-6. PubMed ID: 399858
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.